GlassScriptPhysician profile
Christos E Mandanis
NPI 1770636854
$10,272.48
in general payments reported to CMS, 2019-2025
40 companies · $1,110 in 2025
The $1,110 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,735 · 2020: $1,042 · 2021: $1,609 · 2022: $1,149 · 2023: $576 · 2024: $3,053 · 2025: $1,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,624 · Travel and Lodging: $1,114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,624.35 |
| Travel and Lodging | $1,114.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,349.80 | 2019-2025 | Aveir, Assurity, Allure Quadra |
| Medtronic Vascular, INC. | $1,379.39 | 2019-2020 | |
| Medtronic, INC. | $1,076.93 | 2021-2025 | Micra, Pulseselect |
| Astrazeneca Pharmaceuticals LP | $582.59 | 2019-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $466.17 | 2020-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $447.59 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $401.26 | 2021-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $293.50 | 2019-2025 | Lifevest |
| Novo Nordisk INC | $267.18 | 2024-2025 | Wegovy, Ozempic |
| Sanofi-Aventis U.S. LLC | $264.78 | 2019-2024 | |
| Amgen INC. | $228.93 | 2019-2024 | Repatha |
| Boston Scientific Corporation | $183.44 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, General - Ep |
| E.R. Squibb & Sons, L.L.C. | $136.99 | 2022-2025 | Camzyos, Eliquis |
| Cvrx, INC. | $131.14 | 2021-2025 | Barostim Neo System |
| Biosense Webster, INC. | $130.69 | 2019-2025 | Carto 3 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christos Mandanis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.